Bulletin
Investor Alert

Lineage Cell Therapeutics Inc.

ASE: LCTX

GO
/marketstate/country/us

After Hours

/zigman2/quotes/207994235/composite

$

1.36

Change

-0.01 -0.73%

Volume

Volume 1.41m

Jun 24, 2022, 7:43 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/207994235/composite

Previous close

$ 1.35

$ 1.37

Change

+0.02 +1.48%

Day low

Day high

$1.30

$1.42

Open
Open: 1.35

52 week low

52 week high

$1.10

$2.99

Open

Market cap

$232.53M

Average volume

1.05M

P/E ratio

N/A

Rev. per Employee

$144,918

EPS

-0.29

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/lctx

MarketWatch News on LCTX

  1. Lineage Cell Therapeutics started at buy with $4 stock price target at B. Riley

    8:56 a.m. June 14, 2022

    - Tomi Kilgore

  2. Lineage Cell Therapeutics stock price target raised to $5 from $3 at Maxim Group

    9:14 a.m. Feb. 8, 2021

    - Tomi Kilgore

  3. BioTime started at buy with $3 stock price target at Maxim Group

    8:46 a.m. Jan. 24, 2019

    - Tomi Kilgore

  4. BioTime started at outperform with $6 stock price target at Raymond James

    8:15 a.m. March 31, 2017

    - Tomi Kilgore

  5. 13D Filings

    12:38 a.m. June 28, 2014

    - Barron's Online

  6. 13D Filings

    2:49 a.m. May 10, 2014

    - Barron's Online

  7. 13D Filings

    3:32 a.m. Jan. 4, 2014

    - Barron's Online

  8. BioTime offers equity stake for Geron assets

    9:46 a.m. Oct. 18, 2012

    - MarketWatch.com

  9. Osiris stem-cell therapy wins Canadian approval

    5:42 p.m. May 17, 2012

    - Val Brickates Kennedy

  10. Court upholds stem-cell research funding: reports

    11:45 a.m. July 27, 2011

    - Val Brickates Kennedy

  11. Are stem-cell stocks a good buy?

    3:05 p.m. July 13, 2011

    - Val Brickates Kennedy

  12. Endo, Celgene lead drug stocks lower

    4:53 p.m. Dec. 8, 2009

    - Val Brickates Kennedy

  13. BioTime Q2 revs $195,337 vs $97,297

    7:12 a.m. Aug. 13, 2004

    - Robert Daniel

  14. BioTime Q2 losses 2c vs 6c

    7:11 a.m. Aug. 13, 2004

    - Robert Daniel

  15. 13D Filings

    12:59 a.m. Feb. 24, 2004

    - Barron's Online

  16. BioTime plans rights offering

    9:15 a.m. Oct. 2, 2003

    - Greg Morcroft

  17. 13D Filings

    12:01 a.m. June 10, 2002

    - Barron's Online

  18. Winners and Sinners

    7:03 p.m. Oct. 20, 1997

    - Barron's Online

Analyst Ratings

/news/nonmarketwatch/company/us/lctx

Other News on LCTX

  1. LI, BTU and EDU among premarket gainers

    8:31 a.m. June 14, 2022

    - Seeking Alpha

  2. 10-Q: LINEAGE CELL THERAPEUTICS, INC.

    4:31 p.m. May 12, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  3. Notable earnings after Thursday's close

    5:35 p.m. May 11, 2022

    - Seeking Alpha

  4. Lineage Cell (LCTX) Reports Q4 Loss

    7:25 p.m. March 10, 2022

    - Zacks.com

  5. Notable earnings after Thursday's close

    6:35 p.m. March 9, 2022

    - Seeking Alpha

  6. Loading more headlines...
/news/pressrelease/company/us/lctx

Press Releases on LCTX

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.